Company Directory > CDMO > Wells Pharma of Houston, LLC
Wells Pharma of Houston is an FDA-registered 503B outsourcing facility that specializes in manufacturing compounded sterile preparations for hospitals, surgery centers, and office clinics. The company focuses on providing high-quality, ready-to-use (RTU) medications to address supply chain shortages and improve clinical efficiency. Operating out of Houston, Texas, the company emphasizes its adherence to quality standards and its capacity for large-volume production. As a 503B facility, it operates under specific FDA regulations that allow it to supply compounded drugs to healthcare facilities nationwide, provided they meet current Good Manufacturing Practice (cGMP) requirements.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:503B Outsourcing Facility
SIZE & FINANCIALS
Employees:51-200
Founded:2019
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Compounded sterile preparations
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Hospital systems and surgery centers nationwide
COMPETITION
Position:Niche Player
Competitors:QuVa Pharma, STAQ Pharma, Central Admixture Pharmacy Services (CAPS), Exela Pharma Sciences
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Wells Pharma of Houston, LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Wells Pharma of Houston, LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.